Abeona Therapeutics Inc.ABEONASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average, modest growth trend.
Left:
||||
Year-over-year revenue growth rate
Latest
-100.00%
↓ 15262% below average
Average (39q)
0.66%
Historical baseline
Range
High:519.20%
Low:-224.52%
CAGR
+3.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | 189.02% |
| Q1 2022 | -88.47% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | -57.14% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 100.00% |
| Q4 2018 | -224.52% |
| Q3 2018 | 519.20% |
| Q2 2018 | -48.02% |
| Q1 2018 | 146.98% |
| Q4 2017 | -1.83% |
| Q3 2017 | 0.92% |
| Q2 2017 | 16.67% |
| Q1 2017 | -27.34% |
| Q4 2016 | 39.13% |
| Q3 2016 | -14.02% |
| Q2 2016 | -8.94% |
| Q1 2016 | 9.30% |
| Q4 2015 | -24.56% |